ACTing Minds: An ACT-based Videogame for Mental Health
ACTingMindsRCT
Randomised Controlled Trial for a Novel ACT-based Videogame 'ACTing Minds' to Support Mental Health
1 other identifier
interventional
302
1 country
1
Brief Summary
The goal of this clinical trial is to test whether a single-session Acceptance and Commitment Therapy (ACT) videogame (ACTing Minds) improves psychological flexibility and mental health in adults who report mild to moderate depression, anxiety or stress. The main questions are whether ACTing Minds increases psychological flexibility (CompACT Total) more than a time- and engagement-matched neutral commercial game at the end of the session and again at short-term follow-up (10-13 days), and whether it produces favourable changes in symptoms, wellbeing, social connectedness, health-related quality of life, and short seated heart-rate variability recordings. Researchers will compare ACTing Minds with the neutral game to determine whether the ACT-based experience leads to greater improvements. Participants attend one laboratory visit of about 60 minutes, complete brief questionnaires at baseline, immediately after the session and at short-term follow-up, and provide a short seated ECG at each timepoint for heart-rate variability analysis. The study uses a single-blind, two-arm, randomised, parallel-group design at Swansea University (UK).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable depression
Started Nov 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 14, 2025
CompletedStudy Start
First participant enrolled
November 26, 2025
CompletedFirst Posted
Study publicly available on registry
December 9, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 9, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 9, 2025
CompletedFebruary 12, 2026
February 1, 2026
13 days
November 14, 2025
February 9, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Psychological flexibility (CompACT Total)
CompACT total score; higher scores indicate greater psychological flexibility. Primary estimand is the between-group difference in change from baseline to short-term follow-up (10-13 days post-intervention); post-session estimates will also be reported.
Baseline (Day 0); Immediately post-intervention (≈60 minutes after Baseline); short-term follow-up (10-13 days post-intervention).
Mental-health symptoms (DASS-21 Total)
DASS-21 total score; higher scores indicate greater symptom severity.
Baseline (Day 0); Immediately post-intervention (≈60 minutes after Baseline); Short-term follow-up (10-13 days post-intervention).
Secondary Outcomes (13)
Depressive symptoms (DASS-21 Depression)
Baseline (Day 0); Immediately post-intervention (≈60 minutes after Baseline); Short-term follow-up (10-13 days post-intervention).
Anxiety symptoms (DASS-21 Anxiety)
Baseline (Day 0); Immediately post-intervention (≈60 minutes after Baseline); Short-term follow-up (10-13 days post-intervention).
Stress symptoms (DASS-21 Stress)
Baseline (Day 0); Immediately post-intervention (≈60 minutes after Baseline); Short-term follow-up (10-13 days post-intervention).
Wellbeing (Flourishing Scale)
Baseline (Day 0); Immediately post-intervention (≈60 minutes after Baseline); Short-term follow-up (10-13 days post-intervention).
Social connectedness (Social Connectedness Scale)
Baseline (Day 0); Immediately post-intervention (≈60 minutes after Baseline); Short-term follow-up (10-13 days post-intervention).
- +8 more secondary outcomes
Study Arms (2)
ACTing Minds (ACT videogame)
EXPERIMENTALSingle \~60-minute session on a study-supplied smartphone in the lab; assessments at baseline, post-session, and short-term follow-up (10-13 days post-intervention).
Neutral commercial puzzle game (Monument Valley)
ACTIVE COMPARATOREngagement- and time-matched \~60-minute smartphone session in the lab; assessments at baseline, post-session, and short-term follow-up (10-13 days post-intervention).
Interventions
Single-session (\~60 min) ACT-based videogame integrating acceptance/openness, cognitive defusion, present-moment awareness, values and values-guided action via structured chapters. Delivered on a study-supplied Samsung Galaxy S9+ (Android) under standardised instructions; no therapist guidance during play.
Commercial mobile puzzle game used as an engagement- and time-matched control (\~60 min) with no therapeutic content. Delivered on a study-supplied Samsung Galaxy S9+ (Android) in the lab. Title/version fixed for the trial; procedures and environment identical to the experimental arm. No data are collected within the app.
Eligibility Criteria
You may qualify if:
- Aged 18 years or older
- Able to read and understand English
- Self-reported mild to moderate symptoms of depression, anxiety, or stress
- Provides written informed consent
- Willing and able to attend one \~60-minute laboratory session and complete online follow-up questionnaires 10-13 days later
- Agrees to ECG recording (seated \~5 minutes at each timepoint)
- Willing to play either study videogame on a study-supplied Samsung Galaxy S9+ (Android)
You may not qualify if:
- Current or past severe mental illness (e.g., psychotic disorder, bipolar disorder)
- Current psychotropic medication use (e.g., antidepressants, anxiolytics, antipsychotics, mood stabilisers, stimulants)
- Concurrent psychological therapy (any modality)
- Pregnancy
- Cardiovascular conditions or clinically significant arrhythmias that could affect ECG or HRV measurement or be exacerbated by study procedures
- Implanted cardiac devices (e.g., pacemaker or ICD)
- Any neurological condition, medical condition, or skin condition that would preclude safe ECG electrode placement or comfortable seated recording
- Insufficient English proficiency to provide informed consent or complete study measures
- Any other factor that, in the judgement of the investigators, would compromise safety, data quality, or protocol compliance
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Swansea University, School of Psychology (Singleton Park)
Swansea, Wales, SA2 8PP, United Kingdom
Related Publications (2)
Edwards DJ, Kemp AH. A novel ACT-based video game to support mental health through embedded learning: a mixed-methods feasibility study protocol. BMJ Open. 2020 Nov 16;10(11):e041667. doi: 10.1136/bmjopen-2020-041667.
PMID: 33199427BACKGROUNDGordon TC, Kemp AH, Edwards DJ. Mixed-methods feasibility outcomes for a novel ACT-based video game 'ACTing Minds' to support mental health. BMJ Open. 2024 Mar 29;14(3):e080972. doi: 10.1136/bmjopen-2023-080972.
PMID: 38553053BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Darren J Edwards, PhD
Swansea University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Participants masked to allocation
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
November 14, 2025
First Posted
December 9, 2025
Study Start
November 26, 2025
Primary Completion
December 9, 2025
Study Completion
December 9, 2025
Last Updated
February 12, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, ANALYTIC CODE
- Time Frame
- Data and documents will be made available at article acceptance/publication. If journal processes impose a brief embargo, release will occur within 3 months of acceptance. Materials will be retained indefinitely with versioning; any material updates (e.g., errata, code revisions) will be posted to the same repository. The registry will be updated with the dataset DOI/URL on release.
- Access Criteria
- Open access: no application required. De-identified IPD (questionnaire outcomes, HRV summary indices, mean heart rate, allocation group, age band, gender), data dictionary, SAP, protocol, consent template, and analysis code will be downloadable from a public repository.
We will share de-identified individual participant data (IPD) underlying the published results, including all questionnaire outcomes (CompACT total/subscales, DASS-21 total/subscales, Flourishing, Social Connectedness, EQ-5D index and VAS), heart-rate variability summary indices (lnRMSSD, lnSDNN, lnHF, lnLF, lnLF/HF) and mean heart rate at T1-T3, allocation group, age band and gender. A data dictionary, statistical analysis plan and analysis code will be provided. Raw ECG waveforms and any free-text fields will not be shared. Data will be deposited on the Open Science Framework and released at article acceptance/publication; access will be open (no application) under an appropriate licence.